Assembly Biosciences, Inc.ASMBNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank50
3Y CAGR+95.5%
5Y CAGR-8.4%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+95.5%/yr
vs -57.4%/yr prior
5Y CAGR
-8.4%/yr
Recent acceleration
Acceleration
+152.9pp
Accelerating
Percentile
P50
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 15.88% |
| 2024 | 14.38% |
| 2023 | -30.12% |
| 2022 | 2.12% |
| 2021 | -35.85% |
| 2020 | 24.56% |
| 2019 | 17.89% |
| 2018 | 64.48% |
| 2017 | 33.64% |
| 2016 | 80.27% |